Beneficient files Amended Certificate of Incorporation (EX-3.1)
The company filed an exhibit containing an amended certificate of incorporation, likely regarding stock rights or governance. Market relevance is neutral pending specific operation…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The company filed an exhibit containing an amended certificate of incorporation, likely regarding stock rights or governance. Market relevance is neutral pending specific operation…
Oncolytics Biotech announced plans to hold a Type D meeting with the FDA to design a registrational study for its REO 033 colorectal cancer trial. This regulatory step targets acce…
BNBX received a delisting determination from Nasdaq for failing to maintain a $1.00 bid price threshold. The company is transitioning its shares to the OTCQB Venture Market startin…
Armata Pharmaceuticals received FDA agreement on the Initial Pediatric Study Plan (iPSP) for AP-SA02 to treat resistant staph infections in children. This regulatory milestone adva…
Q32 Bio announced positive toppline results from the SIGNAL-AA trial, showing a 35.3% mean reduction in SALT score. The data demonstrates a differentiated safety profile and effica…
Trio-Tech filed an exhibit updating its third amended bylaws. This governance document adjusts rules for meetings and directors without immediate operational impact.
The FDA released a proposed rule to modernize drug manufacturing registration. The rule targets distributed manufacturing establishments utilizing a 'hub-and-spoke' model.
United Health Products has partnered with NAMSA to sponsor a new clinical study of its CelluSTAT Hemostatic Gauze to help resolve an outstanding FDA warning letter. This collaborat…
BCRG Group Inc. confirmed InnSuites Hospitality Trust's statements concerning their firm in the Form 8-K. This standard response indicates the auditors signed off on procedural det…
TruBridge, Inc. filed an amended and restated certificate of incorporation to authorize 1,000 common shares. This regulatory filing confirms the company's board structure and servi…
The Federal Reserve Board has issued an enforcement action against TS Banking Group and TS Contrarian Bancshares. This regulatory step addresses oversight failures within the finan…
The CARDIO-TTRansform trial for eplontersen did not meet its primary cardiovascular endpoint vs. placebo, though a positive signal was seen in monotherapy. The missed readout prese…
All active patients in MetaVia's Phase 1 Part 3 obesity study reached target doses, indicating favorable tolerability for DA-1726. The company projects no delays to its Q4 2026 top…
AVAX One Technology Ltd. regained compliance with Nasdaq’s minimum bid price requirement after a 10-day closing price above $1.00. This clearance ends delisting concerns and allows…
An independent Data Monitoring Committee recommended proceeding with the Phase 3 study for Trappsol Cyclo. The therapy addresses a significant unmet medical need projected at over …
Sadot Group Inc. submitted a new contract exhibit to the SEC, updating company agreements.
Ernst & Young LLP reviewed and agreed with specific management statements in the July 8-K concerning financial condition. The auditor provides third-party verification of the MD&A …
Skillsoft received NYSE approval to regain compliance with listing standards by September 2027. This plan allows stock to maintain listing status while the company addresses its ma…
The issuer filed a current report with the SEC on July 8, 2026, regarding administrative filing details and entity information.
Upland Software regained compliance with the Nasdaq minimum bid price requirement. This resolution eliminates a delisting threat and protects the company’s public listing status.